Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ansonia Holdings is a Singapore-based investment holding company founded in 1999. It acts as a diversified investor, including significant investments in biotech and pharma, such as financing NRx Pharmaceuticals and holding a stake in Kenon Holdings Ltd. The company's health relevance stems from its investment activities rather than direct drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ansonia Holdings.